Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015".
Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026
Earlier from Dr. Reddy's Laboratories
- Dr. Reddy's Laboratories Ltd. Press Release Jul 23 2026
- Dr. Reddy's Laboratories Ltd. Press Release Jul 13 2026
- Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
- Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States